Peripheral Artery Disease Market is anticipated to expand from $6 billion in 2024 to $109.54 billion by 2034, growing at a CAGR of approximately 33.7%.
The Peripheral Artery Disease (PAD) market encompasses the diagnosis, treatment, and management of PAD, a condition characterized by narrowed arteries reducing blood flow to limbs. This market includes pharmaceuticals, medical devices such as stents and angioplasty balloons, and diagnostic tools. It is driven by rising prevalence due to aging populations and lifestyle factors, advancements in minimally invasive procedures, and increasing healthcare awareness, presenting growth opportunities for innovative therapies and technologies.